Table 2. Relationship of CAPN2 expression and clinicopathological characteristics of patients.
| Variable | Total (%) | CAPN2 expression | ||
|---|---|---|---|---|
| Low (n = 50) | High (n = 24) | P value | ||
| Age (year) | 0.217 | |||
| <60 | 42 | 31 (73.8) | 11 (26.2) | |
| ≥60 | 32 | 19 (59.4) | 13 (40.6) | |
| Gender | 0.201 | |||
| Male | 47 | 29 (61.7) | 18 (38.3) | |
| Female | 27 | 21 (77.8) | 6 (22.2) | |
| Tumor size (cm) | 0.217 | |||
| ≤4 | 42 | 31 (73.8) | 11 (26.2) | |
| >4 | 32 | 19 (59.4) | 13 (40.6) | |
| Histology | 1 | |||
| Clear cell carcinoma | 61 | 41 (67.2) | 20 (32.8) | |
| Others | 13 | 9 (69.2) | 4 (30.8) | |
| Histological grade | 0.048* | |||
| I–II | 62 | 45 (72.6) | 17 (27.4) | |
| III–IV | 12 | 5 (41.7) | 7 (58.3) | |
| Tumor stage | 0.011* | |||
| T1 | 64 | 47 (73.4) | 17 (26.6) | |
| T2–T4 | 10 | 3 (30.0) | 7 (70.0) | |
| Survival | 0.102 | |||
| No | 13 | 6 (46.2) | 7 (53.8) | |
| Yes | 61 | 44 (72.1) | 17 (27.9) | |
*P < 0.05. P values were two-tailed and based on the Pearson chi-square test.